{"book_asymmetry_distribution":[],"carrier_id":null,"cer_runtime_export":{"decision_count":0,"decisions":[],"schema":"velaru-cer-export-v1","transfer_aligned_count":0,"transfer_aligned_ratio":null},"cross_platform_entries":[],"disclaimer":"Anonymized behavioral signals \u2014 not filed loss development. For actuarial correlation study with carrier loss triangles.","entry_count":0,"generated_at":"2026-08-15T23:26:13.290708Z","insurance_lines":["Product liability","Clinical trial E&O"],"schema_version":"velaru-galactic-actuarial-1.0","tam_note":"$200B+ pharma R&D \u00b7 AI in trial design exploding","vertical_key":"pharma","vertical_name":"Pharma / Clinical Trials"}